![]() |
Name |
Amestolkolide D
|
Molecular Formula | C29H36O9 | |
IUPAC Name* |
[(1R,2S,12S,14R,17R,19R,21S)-2,6,6,14,19-pentamethyl-3,8,15,20-tetraoxo-7,16,18-trioxapentacyclo[12.6.1.02,12.05,10.017,21]henicosa-4,10-dien-11-yl]methyl 3-methylbutanoate
|
|
SMILES |
C[C@@H]1C(=O)[C@@H]2[C@@H]3[C@H](O1)OC(=O)[C@@]3(C[C@@H]4[C@@]2(C(=O)C=C5C(=C4COC(=O)CC(C)C)CC(=O)OC5(C)C)C)C
|
|
InChI |
InChI=1S/C29H36O9/c1-13(2)8-20(31)35-12-16-15-9-21(32)38-27(4,5)17(15)10-19(30)29(7)18(16)11-28(6)23-22(29)24(33)14(3)36-25(23)37-26(28)34/h10,13-14,18,22-23,25H,8-9,11-12H2,1-7H3/t14-,18+,22+,23-,25-,28-,29-/m1/s1
|
|
InChIKey |
XJSNMILPWDUZGX-BWTYFMBNSA-N
|
|
Synonyms |
Amestolkolide D
|
|
CAS | NA | |
PubChem CID | 139590898 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 528.6 | ALogp: | 1.5 |
HBD: | 0 | HBA: | 9 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 122.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 38 | QED Weighted: | 0.393 |
Caco-2 Permeability: | -5.145 | MDCK Permeability: | 0.00002320 |
Pgp-inhibitor: | 0.996 | Pgp-substrate: | 0.018 |
Human Intestinal Absorption (HIA): | 0.119 | 20% Bioavailability (F20%): | 0.742 |
30% Bioavailability (F30%): | 0.916 |
Blood-Brain-Barrier Penetration (BBB): | 0.804 | Plasma Protein Binding (PPB): | 66.78% |
Volume Distribution (VD): | 0.515 | Fu: | 39.54% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.087 |
CYP2C19-inhibitor: | 0.195 | CYP2C19-substrate: | 0.27 |
CYP2C9-inhibitor: | 0.283 | CYP2C9-substrate: | 0.033 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.033 |
CYP3A4-inhibitor: | 0.563 | CYP3A4-substrate: | 0.671 |
Clearance (CL): | 10.866 | Half-life (T1/2): | 0.675 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.065 |
Drug-inuced Liver Injury (DILI): | 0.879 | AMES Toxicity: | 0.042 |
Rat Oral Acute Toxicity: | 0.883 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.746 | Carcinogencity: | 0.715 |
Eye Corrosion: | 0.992 | Eye Irritation: | 0.454 |
Respiratory Toxicity: | 0.954 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003925 | ![]() |
0.849 | D0K7HU | ![]() |
0.220 | ||
ENC004709 | ![]() |
0.757 | D09WYX | ![]() |
0.218 | ||
ENC002931 | ![]() |
0.541 | D03ZZK | ![]() |
0.217 | ||
ENC005628 | ![]() |
0.532 | D0Y2YP | ![]() |
0.216 | ||
ENC003927 | ![]() |
0.350 | D0Q4SD | ![]() |
0.216 | ||
ENC005629 | ![]() |
0.336 | D0D2TN | ![]() |
0.215 | ||
ENC003843 | ![]() |
0.303 | D02JNM | ![]() |
0.211 | ||
ENC003847 | ![]() |
0.281 | D09HNR | ![]() |
0.209 | ||
ENC003846 | ![]() |
0.278 | D05AFC | ![]() |
0.207 | ||
ENC002162 | ![]() |
0.275 | D0X4RS | ![]() |
0.207 |